Jason Glanz to Buprenorphine
This is a "connection" page, showing publications Jason Glanz has written about Buprenorphine.
Connection Strength
1.135
-
Health Plan Disenrollment and Mortality After Initiation of Medications for Opioid Use Disorder. JAMA Psychiatry. 2026 May 01; 83(5):491-498.
Score: 0.914
-
Impact of increased criminal penalties for fentanyl possession on initiation and retention on medications for opioid use disorder in Colorado. Int J Drug Policy. 2025 12; 146:105037.
Score: 0.220